MARLBOROUGH, Mass.--(BUSINESS WIRE)--Cytyc Corporation (Nasdaq: CYTC) today announced that its wholly-owned subsidiary, Augusta Medical Corporation, has now purchased over 92 percent of the outstanding shares of common stock of Adeza Biomedical Corporation (Nasdaq: ADZA). Augusta had previously purchased approximately 87.4 percent of Adeza’s outstanding common shares that had been tendered in the initial offering period of its tender offer which expired at 12:00 midnight, New York City time, on March 16, 2007, and has now purchased additional Adeza shares representing approximately 5.0 percent of the outstanding common stock. The subsequent offering period for any and all remaining outstanding Adeza shares will expire at 12:00 midnight, New York City time, on Friday, March 30, 2007.
